Corbus Pharmaceuticals (CRBP)
(Delayed Data from NSDQ)
$51.70 USD
+2.37 (4.80%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $51.71 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.99 | -4.22% |
Earnings Summary
For their last quarter, Corbus Pharmaceuticals (CRBP) reported earnings of -$0.90 per share, beating the Zacks Consensus Estimate of $-1.16 per share. This reflects a positive earnings surprise of 22.41%. Look out for CRBP's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.99 per share, reflecting a year-over-year increase of 56.39%.
Earnings History
Price & Consensus
Zacks News for CRBP
Corbus Pharmaceuticals (CRBP) Upgraded to Buy: Here's Why
CRBP: What are Zacks experts saying now?
Zacks Private Portfolio Services